GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 120 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,312,000 | -11.1% | 34,521 | +5.8% | 0.26% | -28.1% |
| Q2 2018 | $1,475,000 | +90.1% | 32,630 | +103.1% | 0.36% | +60.0% |
| Q1 2018 | $776,000 | +127.6% | 16,069 | +85.2% | 0.22% | +150.0% |
| Q4 2017 | $341,000 | +244.4% | 8,676 | +171.6% | 0.09% | +233.3% |
| Q3 2017 | $99,000 | +7.6% | 3,194 | -4.9% | 0.03% | +8.0% |
| Q2 2017 | $92,000 | -23.3% | 3,358 | +3.3% | 0.02% | -21.9% |
| Q1 2017 | $120,000 | – | 3,250 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |